{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T07:13:14Z","timestamp":1789024394353,"version":"build-2803163510"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T00:00:00Z","timestamp":1758585600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Estimates of HIV incidence and the size of the undiagnosed population are important to monitor epidemic trends, assess progress towards regional and global goals, and inform ongoing prevention and control measures. Previous estimates from Norway date back to 2018 and did not account for pre-migration infection among migrants. This is essential when modelling the HIV epidemic in countries like Norway, where over 80% of new HIV diagnoses are among migrants who reportedly acquired HIV before migration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Method<\/jats:title>\n                    <jats:p>I estimated the incidence of new HIV infections, number undiagnosed and proportion diagnosed overall and in key groups at risk of HIV acquisition up until the end of 2023 in Norway. I used linked national registry data and the ECDC HIV modelling tool, a back-calculation compartmental model that uses routine surveillance data on HIV diagnoses. The modelling tool estimates pre-migration infections by comparing the known date of migration to the estimated date of infection. I generated estimates overall and for four subgroups: Norwegian-born men who have sex with men (MSM), Norwegian-born heterosexual transmission, migrant MSM and migrant heterosexual transmission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The model input data included 7,185 new HIV diagnoses up to the end of 2023, of which 4,266 (59%) were migrants. The model estimated that 86% (95% confidence interval (CI): 83% \u2013 88%) of new infections among migrants were pre-migration infections. Excluding these, there were 13 (95% CI: 11 \u2013 50) new HIV infections in Norway in 2023. There were 234 (95% CI: 207 \u2013 336) undiagnosed PLHIV and the proportion diagnosed was 96.5% (95% CI: 95.1% \u2013 96.9%). The diagnosed fraction was under 95% among Norwegian-born heterosexual transmission (92.6%; 95% CI: 87.1% \u2013 94.5%) and migrant MSM (92.2%; 95% CI: 90.8% \u2013 93.8%).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Overall, Norway has achieved the global target of diagnosing 95% of people living with HIV. The incidence of new HIV infections is low. Existing measures should be maintained and strengthened to further reduce the undiagnosed population and prevent transmission. The lower proportion diagnosed among Norwegian-born persons infected through heterosexual transmission and migrant MSM indicates where larger relative improvements may be made.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12879-025-11541-x","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T07:18:17Z","timestamp":1758611897000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Using linked national registry data and the ECDC HIV modelling tool to estimate HIV incidence and the proportion diagnosed in Norway up to 2023"],"prefix":"10.1186","volume":"25","author":[{"given":"Robert","family":"Whittaker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,23]]},"reference":[{"key":"11541_CR1","unstructured":"Joint United Nations Programme on HIV\/AIDS (UNAIDS). 2024 global AIDS report \u2014 the Urgency of Now: AIDS at a Crossroads. Geneva: UNAIDS; 2024. Available from: https:\/\/www.unaids.org\/sites\/default\/files\/media_asset\/2024-unaids-global-aids-update_en.pdf."},{"key":"11541_CR2","unstructured":"World Health Organization (WHO) Regional Office for Europe. Regional action plans for ending AIDS and the epidemics of viral hepatitis and sexually transmitted infections 2022\u20132030. Copenhagen: WHO; 2023. Available from: https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/369243\/9789289058957-eng.pdf?sequence=7&isAllowed=y."},{"key":"11541_CR3","unstructured":"European Centre for Disease Prevention and Control (ECDC). Continuum of HIV care: Monitoring implementation of the Dublin Declaration on partnership to fight HIV\/AIDS in Europe and Central Asia: 2023 progress report. Stockholm: ECDC; 2024. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/hiv-dublin-continuum-care-progress-report-2023.pdf."},{"key":"11541_CR4","unstructured":"ECDC. HIV platform tool. Stockholm: ECDC; 2021. Available from: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/hiv-platform-tool."},{"key":"11541_CR5","doi-asserted-by":"publisher","unstructured":"Lundgren E, Locke M, Romero-Severson E, Dimitrijevic M, Axelsson M, Andersson E, et al. Sweden surpasses the UNAIDS 95\u201395\u201395 target: estimating HIV-1 incidence, 2003 to 2022. Euro Surveill. 2024;29(42). https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.42.2400058.","DOI":"10.2807\/1560-7917.ES.2024.29.42.2400058"},{"key":"11541_CR6","unstructured":"Norwegian Institute of Public Health. Blod- og seksuelt overf\u00f8rbare infeksjoner i Norge: \u00c5rsrapport 2024. [Blood and sexually transmitted infections in Norway: annual report 2024]. Oslo: Norwegian Institute of Public Health; 2025. Available from: https:\/\/www.fhi.no\/publ\/2025\/arsrapport-2024---blod--og-seksuelt-overforbare-infeksjoner\/."},{"key":"11541_CR7","unstructured":"ECDC. Progress towards reaching the sustainable development goals related to HIV in the European Union and European Economic Area. Monitoring implementation of the Dublin Declaration on partnership to fight HIV\/AIDS in Europe and Central Asia \u2013 2024 progress report. Stockholm: ECDC; 2024. Available from: https:\/\/www.ecdc.europa.eu\/sites\/default\/files\/documents\/hiv-evidence-brief-progress-towards-sustainable-development-goals-2023.pdf."},{"issue":"1","key":"11541_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/s12879-020-05178-1","volume":"20","author":"R Whittaker","year":"2020","unstructured":"Whittaker R, Case KK, Nilsen O, Blystad H, Cowan S, Kl\u00f8vstad H, et al. Monitoring progress towards the first UNAIDS 90\u201390-90 target in key populations living with HIV in Norway. BMC Infect Dis. 2020;20(1):451.","journal-title":"BMC Infect Dis"},{"key":"11541_CR9","unstructured":"Norwegian Institute of Public Health. Hivinfeksjon\/Aids \u2013 h\u00e5ndbok for helsepersonell. [HIV\/AIDS \u2013 handbook for health care professionals]. Oslo: Norwegian Institute of Public Health; 2025. Available from: https:\/\/www.fhi.no\/sm\/smittevernhandboka\/sykdommer-a-a\/hivinfeksjonaids\/?term=. Accessed: 09 June 2025."},{"key":"11541_CR10","unstructured":"Helse Norge. Rapid HIV test. Oslo: Helse Norge; 2024. Available from: https:\/\/www.helsenorge.no\/en\/sykdom\/hiv-aids\/rapid-HIV-test\/. Accessed: 09 June 2025."},{"key":"11541_CR11","unstructured":"Helseutvalget. Sjekkpunkt. Oslo: Helseutvalget; 2025. Available from: https:\/\/www.helseutvalget.no\/en\/sjekkpunkt. Accessed: 09 June 2025."},{"key":"11541_CR12","unstructured":"The Norwegian Directorate of Health. Helsetjenester til asyls\u00f8kere, flyktninger og familiegjenforente. [Healthcare services for asylum seekers, refugees and their family members]. Oslo: The Norwegian Directorate of Health; 2024. Available from: https:\/\/www.helsedirektoratet.no\/veiledere\/helsetjenester-til-asylsokere-flyktninger-og-familiegjenforente. Accessed: 09 June 2025."},{"issue":"3","key":"11541_CR13","doi-asserted-by":"publisher","first-page":"e700","DOI":"10.1093\/infdis\/jiae147","volume":"230","author":"R Whittaker","year":"2024","unstructured":"Whittaker R, Midtb\u00f8 JE, Klovstad H. Monitoring progress towards the elimination of hepatitis C as a public health threat in Norway: a modelling study among people who inject drugs and immigrants. J Infect Dis. 2024;230(3):e700\u201311. https:\/\/doi.org\/10.1093\/infdis\/jiae147.","journal-title":"J Infect Dis"},{"key":"11541_CR14","unstructured":"Norwegian Institute of Public Health. Meldingskriterier for sykdommer i msis. [Case definitions for notifiable diseases]. Oslo: Norwegian Institute of Public Health; 2025. Available from: https:\/\/www.fhi.no\/publ\/informasjonsark\/meldingskriterier-for-sykdommer-i-msis\/. Accessed: 09 June 2025."},{"key":"11541_CR15","doi-asserted-by":"publisher","unstructured":"Whittaker R, Nilsen O, Myrberg AJ, Angeltvedt RM, Bergersen BM, Kl\u00f8vstad H. Norway is on the verge of ending the HIV epidemic. Tidsskr Nor Laegeforen. 2020;140(18). https:\/\/doi.org\/10.4045\/tidsskr.20.0748.","DOI":"10.4045\/tidsskr.20.0748"},{"key":"11541_CR16","unstructured":"Norsk kvalitetsregister for HIV. \u00c5rsrapport for 2023. [Annual report for 2023]. Oslo: University Hospital and the Norwegian Institute of Public Health; 2024. Available from: https:\/\/www.kvalitetsregistre.no\/4acc55\/siteassets\/dokumenter\/arsrapporter\/hivregisteret\/arsrapportnorhiv_2023_oppdatert.pdf."},{"key":"11541_CR17","unstructured":"The Norwegian Tax Administration. National population register. Available from: https:\/\/www.skatteetaten.no\/en\/person\/national-registry\/. Accessed: 09 June 2025."},{"issue":"2","key":"11541_CR18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/QAI.0000000000002745","volume":"88","author":"N Pantazis","year":"2021","unstructured":"Pantazis N, Rosinska M, van Sighem A, Quinten C, Noori T, Burns F, et al. Discriminating between premigration and postmigration HIV acquisition using surveillance data. J Acquir Immune Defic Syndr. 2021;88(2):117\u201324.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"11541_CR19","doi-asserted-by":"publisher","first-page":"e49","DOI":"10.1017\/S0950268824000372","volume":"152","author":"S Mann","year":"2024","unstructured":"Mann S, Mougammadou Z, Wohlfahrt J, Elmahdi R. Post-migration HIV acquisition: a systematic review and meta-analysis. Epidemiol Infect. 2024;152:e49.","journal-title":"Epidemiol Infect"},{"key":"11541_CR20","doi-asserted-by":"publisher","unstructured":"HIV Transmission Elimination AMsterdam (H-TEAM) Initiative. A 95% decline in estimated newly acquired HIV infections, Amsterdam, 2010 to 2022. Euro Surveill. 2023;28(40). https:\/\/doi.org\/10.2807\/1560-7917.ES.2023.28.40.2300515.","DOI":"10.2807\/1560-7917.ES.2023.28.40.2300515"},{"issue":"11","key":"11541_CR21","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1111\/hiv.13425","volume":"23","author":"S Croxford","year":"2022","unstructured":"Croxford S, Stengaard AR, Brannstrom J, Combs L, Dedes N, Girardi E, et al. Late diagnosis of HIV: an updated consensus definition. HIV Med. 2022;23(11):1202\u20138.","journal-title":"HIV Med"},{"issue":"48","key":"11541_CR22","doi-asserted-by":"publisher","first-page":"2300642","DOI":"10.2807\/1560-7917.ES.2023.28.48.2300642","volume":"28","author":"J Reyes-Urue\u00f1a","year":"2023","unstructured":"Reyes-Urue\u00f1a J, Marrone G, Noori T, Kuchukhidze G, Martsynovska V, Hetman L, et al. HIV diagnoses among people born in Ukraine reported by EU\/EEA countries in 2022: impact on regional HIV trends and implications for healthcare planning. Euro Surveill. 2023;28(48):2300642.","journal-title":"Euro Surveill"},{"key":"11541_CR23","doi-asserted-by":"publisher","unstructured":"Bremer V, Pharris A. Five years to 2030: reaching underserved populations is key to ending the AIDS epidemic in Europe. Euro Surveill. 2024;29(48). https:\/\/doi.org\/10.2807\/1560-7917.ES.2024.29.48.2400778.","DOI":"10.2807\/1560-7917.ES.2024.29.48.2400778"},{"key":"11541_CR24","first-page":"101243","volume":"52","author":"M Parczewski","year":"2025","unstructured":"Parczewski M, Gokengin D, Sullivan A, de Amo J, Cairns G, Bivol S, et al. Control of HIV across the WHO European region: progress and remaining challenges. Lancet Reg Health. 2025;52:101243.","journal-title":"Lancet Reg Health"},{"key":"11541_CR25","doi-asserted-by":"publisher","unstructured":"Isosomppi S, Mutru M, Ollgren J, Brummer-Korvenkontio H, Liitsola K, Sutinen J, et al. Use of healthcare services preceding HIV diagnosis - missed opportunities for earlier diagnosis, Finland, 1996 to 2019. Euro Surveill. 2025;30(18). https:\/\/doi.org\/10.2807\/1560-7917.ES.2025.30.18.2400610.","DOI":"10.2807\/1560-7917.ES.2025.30.18.2400610"},{"issue":"10","key":"11541_CR26","doi-asserted-by":"publisher","first-page":"e0311114","DOI":"10.1371\/journal.pone.0311114","volume":"19","author":"V Martinez Martinez","year":"2024","unstructured":"Martinez Martinez V, Ormel H, de Op Coul ELM. Barriers and enablers that influence the uptake of HIV testing among heterosexual migrants in the Netherlands. PLoS ONE. 2024;19(10):e0311114.","journal-title":"PLoS ONE"},{"key":"11541_CR27","unstructured":"Norwegian Medical Association. Faglige retningslinjer for oppf\u00f8lging og behandling av hiv i Norge. [National guidelines for the follow-up and treatment of HIV in Norway]. Oslo: Norwegian Medical Association; 2024. Available from: https:\/\/hivfag.no\/images\/2024\/hivretningslinjer2024.pdf."},{"key":"11541_CR28","unstructured":"HIV Norge. Hiv og stigma i helsevesenet. [HIV and stigma in healthcare]. Oslo: HIV Norge; 2024. Available from: https:\/\/hivnorge.no\/nyheter\/hiv-og-stigma-i-helsevesenet\/#:~:text=En%20europeisk%20unders%C3%B8kelse%20viser%20at,overf%C3%B8ring%20og%20forebygging%20av%20hiv. Accessed: 09 June 2025."},{"issue":"5","key":"11541_CR29","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/hiv.13606","volume":"25","author":"DC Krankowska","year":"2024","unstructured":"Krankowska DC, Lourida P, Quirke SM, Woode Owusu M, Weis N, Group EWMWW. Barriers to HIV testing and possible interventions to improve access to HIV healthcare among migrants, with a focus on migrant women: results from a European survey. HIV Med. 2024;25(5):554\u201364.","journal-title":"HIV Med"},{"key":"11541_CR30","unstructured":"GBD 2021 HIV Collaborators. Global, regional, and national burden of HIV\/AIDS, 1990\u20132021, and forecasts to 2050, for 204 countries and territories: the Global Burden of Disease Study 2021. Lancet HIV. 2024;11(12):e807-e22."},{"key":"11541_CR31","unstructured":"Norwegian Institute of Public Health. NORSURV. Oslo: Norwegian Institute of Public Health; 2024. Available from: https:\/\/www.fhi.no\/en\/projects\/norsurv\/. Accessed: 09 June 2025."},{"issue":"2","key":"11541_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/QAI.0000000000003479","volume":"97","author":"SA McDonald","year":"2024","unstructured":"McDonald SA, Yeung A, Nandwani R, Clutterbuck D, Wallace LA, Cullen BL, et al. A statistical model for inference of recent and incident HIV infection using surveillance data on individuals newly diagnosed with HIV infection in Scotland. J Acquir Immune Defic Syndr. 2024;97(2):117\u201324.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"11541_CR33","unstructured":"Norwegian Institute of Public Health. Elektronisk laboratoriemelding til MSIS og laboratoriedatabasen. [Electronic laboratory notification to MSIS and the laboratory database].\u00a0Oslo: Norwegian Institute of Public Health; 2023. Available from: https:\/\/www.fhi.no\/hn\/helseregistre-og-registre\/msis\/elektronisk-laboratoriemelding-til-msis-og-laboratoriedatabasen\/. Accessed: 09 June 2025."}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11541-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-025-11541-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-025-11541-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T11:41:40Z","timestamp":1781610100000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-025-11541-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,23]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["11541"],"URL":"https:\/\/doi.org\/10.1186\/s12879-025-11541-x","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,23]]},"assertion":[{"value":"17 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Ethical approval for this study was granted by the Regional Committees for Medical and Health Research Ethics Southeast Norway (reference number 706180). The need for informed consent was waived by the ethics committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1115"}}